Biogen BIIB
NASDAQ BIIB
$253.40 +2.92 (+1.17%)
At close: Nov 13, 2026 · 4:00 PM EST

Biogen (BIIB) Gains from Investment Securities (2009 - 2026)

Updated

Analysis

Biogen (BIIB) Gains from Investment Securities (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Biogen 37.46 Bn 26.77 Bn 2.06 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -33.40 Mn
Jun 30, 2026 42.80 Mn
Mar 31, 2026 19.00 Mn
Dec 31, 2025 14.40 Mn
Sep 30, 2025 -500,000.00
Jun 30, 2025 7.70 Mn
Mar 31, 2025 -40.90 Mn
Dec 31, 2024 -78.70 Mn
Sep 30, 2024 38.90 Mn
Jun 30, 2024 -30.30 Mn
Mar 31, 2024 -31.30 Mn
Dec 31, 2023 -1.40 Mn
Sep 30, 2023 -302.50 Mn
Jun 30, 2023 106.40 Mn
Mar 31, 2023 -79.60 Mn
Jun 30, 2022 1.70 Bn
Mar 31, 2022 -191.10 Mn
Dec 31, 2021 -116.30 Mn
Sep 30, 2021 -426.90 Mn
Jun 30, 2021 154.00 Mn
API Access

Biogen Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=BIIB&period=max&api_key=YOUR_API_KEY